Economy

Securities Analyst Recommendations: Anthem, Inc. (ANTM), IdaCorp, Inc. (IDA)

Investors and Traders continue to monitor technical levels of shares of TherapeuticsMD, Inc. The firm owned 7,586 shares of the company's stock after selling 118,371 shares during the period. A low ratio will specify that there is a probable undervaluation, while a ratio that is comparatively high above the average may indicate overvaluation.

A number of other institutional investors have also recently bought and sold shares of the business. Investors who are keeping close eye on the stock of Anthem, Inc. The percentage of shares being held by the company management was 0.1% while institutional stake was 91.1%. For the most recent quarter, quick ratio was 0, current ratio was 0, LT Debt/Equity ratio was 0.57 and Total Debt/Equity ratio stands at 0.62, while Payout ratio is 0.241.

Looking forward, the company's quarterly earnings are expected to come at $2.43 in the three months through September 2017 and $1.35 in the quarter ending December 2017, reflecting -0.82% and -23.3% growth, respectively. Finally, Point View Wealth Management Inc. boosted its stake in Anthem by 5.0% in the first quarter. The overall volume in the last trading session was 1.25 million shares. Focused Wealth Management Inc purchased a new position in Anthem in the 1st quarter valued at approximately $149,000. FMR LLC grew its stake in Anthem by 8.2% during the 1st quarter. 258,584 shares of the company's stock were exchanged. Insiders own 0.36% of the company's stock.

If we look at the Volatility of Anthem, Inc.

In recent trading day TherapeuticsMD, Inc. The share last price represents downtick move of -21.28% in value from company's 52-Week high price and shows 86.57% above change in value from its 52-Week low price. The stock's last price was higher from the average trading price of 50 days recorded at $191.56 while enlarging the period to 200 trading days, the average price was $171.7. The stock has a market capitalization of $49.88 billion, a price-to-earnings ratio of 17.962 and a beta of 0.70.

Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, November 2nd. The firm had revenue of $22.20 billion for the quarter, compared to analyst estimates of $22.25 billion. YTD information is useful for analyzing business trends or comparing performance data, and the acronym often modifies concepts such as investment returns, earnings and net pay.

Annual EPS growth Past 5 years is 4.9 percent. On average, equities analysts predict that Anthem, Inc. will post $11.83 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. The ex-dividend date is Thursday, September 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.44%. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & worldwide trademark and copyright laws. "(ANTM)" was first reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & worldwide copyright laws. The original version of this piece can be read at https://www.truebluetribune.com/2017/09/12/south-state-corp-grows-holdings-in-anthem-inc-antm.html.

ANTM has been the subject of several recent research reports. Citigroup Inc. reaffirmed a "buy" rating and issued a $205.00 price objective on shares of Anthem in a research note on Wednesday, June 28th. Jefferies Group LLC restated a "hold" rating and issued a $204.00 target price on shares of Anthem in a research note on Sunday, August 20th. Finally, Bank of America Corporation raised their price objective on shares of Anthem from $224.00 to $228.00 and gave the company a "buy" rating in a research note on Friday, July 14th. The company has a consensus rating of "Buy" and a consensus target price of $183.94.

In other news, EVP Thomas C. Zielinski sold 9,127 shares of the firm's stock in a transaction dated Thursday, August 10th. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Following the transaction, the executive vice president now directly owns 26,571 shares in the company, valued at $5,081,703.75. The stock was sold at an average price of $197.00, for a total value of $4,161,625.00. Following the completion of the transaction, the insider now owns 87,668 shares in the company, valued at $17,270,596. The disclosure for this sale can be found here. The portion of a company's profit allocated to each outstanding share of common stock was $10.57 a share in the trailing twelve months.



Like this

Latest


13 September 2017
PHH Corp (NYSE:PHH) Sees Significantly Higher Trading Volume
Zacks Investment Research upgraded shares of PHH Corp from a "sell" rating to a "hold" rating in a report on Saturday, July 22nd. This repurchase authorization authorizes the credit services provider to buy up to 26.9% of its stock through a dutch auction.

13 September 2017
Olive Garden's New Never Ending Pasta Pass Is Better Than Ever
The itinerary is still being finalized, but will start and end in Rome and include stops in Florence, Assisi, and Siena. And yes, that does mean airfare, hotel and all kinds of Italian excursions for two people for just an extra $100.

13 September 2017
Itau Unibanco Holding SA (ITUB)
A number of analysts offered their Estimated Earnings analysis for Itau Unibanco Holding S.A. ( ITUB ) for the current quarter. This repurchase authorization authorizes the bank to repurchase shares of its stock through open market purchases.

13 September 2017
Liberty Global PLC (LILAK) Shares Sold by White Elm Capital LLC
Vulcan Value Partners Llc increased Mckesson Corp (NYSE:MCK) stake by 1.78 million shares to 3.46M valued at $486.13M in 2016Q4. This is based on a numerical chart where each stock recommendation (Buy, Sell, Hold) is translated into a numerical equivalent.

13 September 2017
(CVS) is up at $80.43 CVS Health Makes Overdose-Reversal Drug…
The pharmacy operator reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.02. Pettee Investors Inc. bought a new position in shares of CVS Health Corporation during the 1st quarter valued at about $214,000.

13 September 2017
Verizon Communications Inc. (VZ) -3.42% away from 20 SMA
Zacks Lowered Verizon Communications from a "hold" recommendation to a "sell" recommendation in a analysis note on Tue, Jun 20th. They expect this year's earnings to fall -1.81% year-over-year to $3.79, followed by 2.37% growth in the next year to $3.88.

12 September 2017
Nu Skin Enterprises, Inc. (NUS) Shares Bought by Legal & General Group Plc
Jensen Investment Management holdings in Nu Skin Enterprises were valued $692,000 as of its latest document with the SEC (SEC). TheStreet raised shares of Nu Skin Enterprises from a "c+" rating to a "b" rating in a research note on Wednesday, August 2nd.

12 September 2017
Facelifted Kia Sorento arrives at the Frankfurt Motor Show
The Picanto X-Line borrows styling cues from Kia's larger crossover and SUV models, such as the Sportage and the Sorento. In addition, a new GT Line specification has been introduced which sits at the top of the Sorento range.

12 September 2017
Chesapeake Energy Corporation (CHK) closed at $3.63 in the last trading session
On Wednesday, May 31 RYAN THOMAS L bought $374,775 worth of Chesapeake Energy Corporation (NYSE: CHK ) or 75,000 shares. Strengthening these views, the company is estimating to achieve earnings per share (EPS ) growth of 5.71% in next year.

12 September 2017
Chevron Corporation New (NYSE:CVX) Short Interest Increased By 5.33%
It is down 2.90% since September 11, 2016 and is downtrending. "Inc, Infinera Corp, Bonanza Creek ..." on August 15, 2017. Fisher Asset Management LLC increased its holdings in shares of Chevron Corporation by 1.0% during the 1st quarter.



Recommended